Pomegranate (P. Granatum) Peel Compress
Conditions
Keywords
pain, osteoarthritis, rheumatologic diseases, physical function, stiffness, nursing
Brief summary
Osteoarthritis is the most common type of arthritis among rheumatologic diseases. Complementary therapies are one of the effective methods for pain control. This study was planned as a randomized controlled experimental study. For this purpose, patients diagnosed with knee osteoarthritis who applied to the Orthopedics Outpatient Clinic will be included. It was calculated that the study would include at least 67 patients. The study will be collected using patient information form, descriptive characteristics form, Visual Analog Scale (VAS) and WOMAC osteoarthritis application scale. It was planned as a randomized controlled experimental study to evaluate the effect of pomegranate peel (P. granatum) compress application on pain and function status. The study was divided into 3 groups as Pomegranate (Punica granatum) peel compress, hot compress and control group. Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.
Detailed description
This randomized controlled experimental study was conducted to evaluate the effect of pomegranate (Punica granatum) peel compress application on pain, stiffness and physical function in individuals with knee osteoarthritis.
Interventions
BEHAVIORALPomegranate (Punica granatum) peel compress
Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.
BEHAVIORALHot compress
Hot compress was applied 3 days a week for 3 weeks.
Sponsors
TC Erciyes University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Visual analog scale score of 3 and above, * those aged 45 and over, * Diagnosed with knee OA by a physician according to the criteria of the American - Rheumatology Association (ARD), * pain lasting at least 1 month or longer, * not included in any physical therapy program during the research period, a * capable of answering research questions, * agreeing to participate in the research by giving verbal and written consent
Exclusion criteria
* with a defined psychiatric illness, * having vision and hearing problems, * diagnosed with complex disease such as malignant, * having a wound in the application area, * with a diagnosed vascular disease, * the patient's other inflammatory disease such as rheumatoid arthritis, gout, fibromyalgia * who have had serious trauma or surgery in the last 6 months, * who have received DMARDS or intra-articular steroid injection therapy in the last 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scale | The scale was filled in the baseline | A VAS consisting of a 10-centimeter horizontal line, anchored evenly by numbers from 0 to 10, was used to assess the patient's pain and willingness to repeat the procedure. The number 0 was identical to having no pain while the number 10 corresponded to maximal pain that can be experienced by the patient |
| WOMAC Osteoarthritis Index | The scale was filled in the baseline | The WOMAC index is composed of 24 items and 3 subdimensions (pain, stiffness, and physical function). The participants are asked to rate pain (5 questions), stiffness (2 questions), and difficulties encountered in physical functioning (17 questions) during the day (24 hours). The index is a 5-point Likert-type scale, where 0 is none, 1 mild, 2 moderate, 3 severe, and 4 very severe. Pain scores range from 0e20 points, stiffness scores from 0e8 points, and difficulties in physical function scores from 0e68 points. Higher scores indicate increased pain and stiffness, impairment in physical functioning, and higher levels of physical limitation. |
Countries
Turkey (Türkiye)
Outcome results
None listed